Neurana Pharmaceuticals Announces Publication of Driving Study SAN DIEGO, Calif., May 12, 2020 – Neurana Pharmaceuticals, Inc., a biotechnology pharmaceutical company focused on the treatment of neuromuscular conditions, today announced the publication of a driving...
Kit Check Announces New Sanitization Feature and Medication Tagging Milestone Company’s RFID solution, now with Sanitization Check feature to better support COVID-19 frontline providers, reaches 100 million medications tagged WASHINGTON (May 4, 2020) — Kit Check™, the...
Rallybio Completes $145 Million Series B Financing and Announces Plans to Advance Lead Product Candidate into the Clinic in 2H 2020 — Financing Led by Pivotal bioVenture Partners — Company Announces Lead Product Candidate for the Prevention of a Potentially...
FDA Grants Full Approval of Deciphera Pharmaceuticals’ QINLOCK™ (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor -QINLOCK Significantly Improved Progression-Free Survival and Showed Clinically Meaningful Overall Survival in INVICTUS Phase 3...
BrightInsight and CSL Behring Announce Global Digital Health Partnership to Improve Treatment Experience for Patients with Rare Diseases CSL Behring selects the BrightInsight Platform to build and manage its digital health solutions within a regulatory-compliant...
Recent Comments